Wesana Health is an emerging life sciences company championing the development and delivery of therapies, including psychedelics, to treat traumatic brain injury (TBI) and related conditions. Through extensive clinical research and academic partnerships, they're developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological and mental health ailments caused by trauma.
Wesana Health is focused on developing therapeutic treatment options for 4 mental health disorders: traumatic brain injuries, post-traumatic stress disorder, anxiety, and depression.
Daniel Carcillo, CEO/Founder
Chad Bronstein, Executive Chairman/Co-Founder
Mark Wingertzahn, PhD, Chief Science Officer
Stephan Bart, MD CPI, Chief Medical Officer